Episode Details
Back to Episodes
First PCSK9 Pill Approved for High Cholesterol | Irvine News
Description
FDA just approved Merck’s groundbreaking new cholesterol pill, Lipfendra—the first oral drug targeting PCSK9, a protein that clears bad cholesterol. It’s a game-changer for patients on statins who still struggle with high LDL, offering up to 55% reduction in just six months with minimal side effects. Fast-tracked for its potential to save millions from heart disease, the pill must be taken on an empty stomach, but could finally make advanced cholesterol treatment widely accessible.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/560875e7e3b44564